{"retracted":false,"update":{"timestamp":1448928000000,"doi":"10.1016/j.bcmd.2015.08.005","type":"err"},"doi":"10.1016/j.bcmd.2014.02.008","journal":"Blood Cells, Molecules, and Diseases","publisher":"Elsevier BV","title":"Corrigendum to “ApoptomiRs expression modulated by BCR–ABL is linked to CML progression and imatinib resistance” [Blood Cells Mol. Dis. 53 (1–2) (June–August 2014) 47–55]"}
